Alpha-1 antitrypsin deficiency (AATD ... Six miRNAs were selected to test their ability to discriminate liver disease in AATD. These were validated for their specificity and sensitivity in ...
Shares of Wave Life Sciences surged to a four-year high Wednesday after the company ... its experimental treatment in patients with alpha-1 antitrypsin deficiency. In this condition, the liver ...
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder associated with liver disease, ranging from fibrosis to ...
A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...